Hanna G M, Lau-Cam C A
US Food and Drug Administration, Northeast Regional Laboratory, Brooklyn, NY 11232, USA.
J AOAC Int. 1996 Jul-Aug;79(4):833-8.
A simple, accurate, and specific 1H NMR spectroscopic method was developed for the assay of diatrizoate meglumine or the combination diatrizoate meglumine and diatrizoate sodium in commercial solutions for injection. A mixture of injectable solution and sodium acetate, the internal standard, was diluted with D2O and the 1H NMR spectrum of the solution was obtained. Two approaches were used to calculate the drug content, based on the integral values for the -N-CO-CH3 protons of diatrizoic acid at 2.23 ppm, and -N-CH3 protons of meglumine at 2.73 ppm, and the CH3-CO-protons of sodium acetate at 1.9 ppm. Recoveries (mean +/- standard deviation) of diatrizoic acid and meglumine from 10 synthetic mixtures of various amounts of these compounds with a fixed amount of internal standard were 100.3 +/- 0.55% and 100.1 +/- 0.98%, respectively. In addition to providing a direct means of simultaneously assaying diatrizoic acid and meglumine, the proposed NMR method can also be used to identify diatrizoate meglumine and each of its molecular components.
开发了一种简单、准确且特异的1H核磁共振光谱法,用于测定市售注射用溶液中泛影葡胺或泛影葡胺与泛影酸钠的混合物。将注射用溶液与内标物醋酸钠的混合物用D2O稀释,然后获得该溶液的1H核磁共振谱。基于2.23 ppm处泛影酸的-N-CO-CH3质子、2.73 ppm处葡甲胺的-N-CH3质子以及1.9 ppm处醋酸钠的CH3-CO-质子的积分值,采用两种方法计算药物含量。从含有固定量内标的不同量这些化合物的10种合成混合物中回收泛影酸和葡甲胺的回收率(平均值±标准差)分别为100.3±0.55%和100.1±0.98%。除了提供同时测定泛影酸和葡甲胺的直接方法外,所提出的核磁共振方法还可用于鉴别泛影葡胺及其每种分子成分。